Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufang Zaofan Wan (Compound Soap Alum Pills) is a Traditional Chinese Medicine (TCM) formula developed and manufactured by Xi'an Haoqijun Pharmaceutical. It is primarily indicated for the treatment of various blood disorders, including aplastic anemia, iron deficiency anemia, and thrombocytopenia. The formula is designed to stimulate bone marrow hematopoiesis, thereby increasing the levels of hemoglobin, red blood cells, white blood cells, and platelets. It is also used to mitigate myelosuppression induced by chemotherapy, radiotherapy, or targeted therapies such as PARP inhibitors. The primary active component is soap alum (melanterite/ferrous sulfate), which is combined with herbal ingredients such as ginseng and astragalus to enhance its hematopoietic and immune-modulating effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fufang zaofan wan.